Literature DB >> 21981553

Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?

Eric Chung1, Ling De Young, Gerald B Brock.   

Abstract

INTRODUCTION: At least 20% of men with Peyronie's disease (PD) suffer from erectile dysfunction (ED). The fundamental mechanism is thought to arise from the progression of penile fibrosis, which was initially limited to the PD plaque within the tunica albuginea. However, recent studies have highlighted the possibility of fibrosis of the cavernosal vessel media wall leading to impairment of arterial inflow. AIM: To evaluate the penile duplex ultrasonographic findings in PD of impotent men and to determine whether early features of PD might predict clinical progression. MAIN OUTCOME MEASURES: Patient demographic, comorbidities, International Index of Erectile Function-5 scores, surgical intervention, and physical findings were documented. Penile curvature, plaque size, and peak systolic velocity (PSV) and end-diastolic velocity (EDV) on color duplex ultrasonography (CDU) were recorded.
METHODS: We performed a retrospective review of all men presenting with penile curvature and length loss who underwent penile CDU between January 2001 and January 2010.
RESULTS: A total of 1,120 men underwent penile CDU during the 10-year period. Complete information was obtained in 810 men; 250 men complained of decreased penile rigidity, while 150 men were unable to sustain erection. Comorbidities were similar between men with PD with and without ED. Tunical thickening (65%) was the most common CDU feature, and mean cumulative calcifications was 24.2 mm(2) (1-360 mm(2) , standard deviation 76). The PSV and EDV on the right cavernosal artery were 14.2 cm/second and 3.5 cm/second, while the left cavernosal artery measurements were 15.1 cm/second and 3.2 cm/second. Multivariate logistic regression model showed strong correlation between plaque size and development of ED. Both veno-occlusive dysfunction and impaired cavernosal arterial inflow were associated with ED.
CONCLUSIONS: Veno-occlusive dysfunction and impaired cavernosal arterial inflow contributed to the development of ED, and larger plaque size is a strong predictor of surgical intervention.
© 2011 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2011        PMID: 21981553     DOI: 10.1111/j.1743-6109.2011.02501.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  16 in total

1.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

2.  Surgical Management for Peyronie's Disease.

Authors:  Robert L Segal; Arthur L Burnett
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

Review 3.  Evaluation of young men with organic erectile dysfunction.

Authors:  Dimitri Papagiannopoulos; Narenda Khare; Ajay Nehra
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

4.  Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases.

Authors:  Gianni Paulis; Gennaro Romano; Andrea Paulis
Journal:  Res Rep Urol       Date:  2016-07-18

5.  Diagnostic value of four-dimensional CT angiography in arterial erectile dysfunction using 320-detector row dynamic volume CT.

Authors:  Cheng-Cheng Xu; Xin-Zhong Ruan; Yi-Fan Tang; Jiao-Hai Pan; Guo-Yao Wang; Qiu-Li Huang
Journal:  Biosci Rep       Date:  2017-08-21       Impact factor: 3.840

6.  Penile Hemodynamic Response to Phosphodiesterase Type V Inhibitors after Cavernosal Sparing Inflatable Penile Prosthesis Implantation: A Prospective Randomized Open-Blinded End-Point (PROBE) Study.

Authors:  Adham Zaazaa; Michaela Bayerle-Eder; Ramzy Elnabarawy; Mahmoud Elbitar; Taymour Mostafa
Journal:  Adv Urol       Date:  2021-06-28

Review 7.  Peyronie's disease: A contemporary review of non-surgical treatment.

Authors:  Laurence A Levine
Journal:  Arab J Urol       Date:  2013-05-28

Review 8.  A review of the epidemiology and treatment of Peyronie's disease.

Authors:  Kevin A Ostrowski; John R Gannon; Thomas J Walsh
Journal:  Res Rep Urol       Date:  2016-04-29

Review 9.  Peyronie's disease: contemporary review of non-surgical treatment.

Authors:  Laurence A Levine
Journal:  Transl Androl Urol       Date:  2013-03

Review 10.  Collagenase Clostridium histolyticum in the treatment of Peyronie's disease: patient selection and perspectives.

Authors:  Paige K Kuhlmann; Kenneth J DeLay; James Anaissie; Wayne Jg Hellstrom; Faysal A Yafi
Journal:  Patient Prefer Adherence       Date:  2017-03-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.